← Eichor
Condition: Esophageal Lesion Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Esophageal Lesion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Validation of AI-ENDO System in Endoscopic Submucosal Dissection
NA · 1 location(s) · Chinese University of Hong Kong · NCT07392268
Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions
NA · 3 location(s) · Laura Boer · NCT06611176
Esophageal Temperature During PVI Using Q-DOT Micro
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT06392932
Endoscopic Resection of Gastrointestinal Neoplasms
Phase N/A · 1 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT04780256
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967
Endoscopic Submucosal Dissection (ESD)
Phase N/A · 1 location(s) · AdventHealth · NCT05468008
EMR Versus ESD for Barrett's Neoplasia
NA · 6 location(s) · St. Antonius Hospital · NCT05276791
Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06354218
Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions
Phase N/A · 1 location(s) · Baylor College of Medicine · NCT06476678
PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06354140
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00242723
To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy
NA · 1 location(s) · Portuguese Oncology Institute, Coimbra · NCT06696209
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Phase 2 · 1 location(s) · University Medical Center Groningen · NCT05745857
Screening for Early Gastric Cancer in Shaanxi Province
Phase N/A · 1 location(s) · Second Affiliated Hospital of Xi'an Jiaotong University · NCT05291728
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.